Funded Tech Companies
Novadip Biosciences
Researching who provided funding to Novadip Biosciences? Invest BW, Sambrinvest and Wallonie Entreprendre joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Novadip Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Watson & Crick Hill, Rue Granbonpré 11,
Mont-Saint-Guibert, 1435
Belgium
Mont-Saint-Guibert, 1435
Belgium
Phone
Website
Email Address
Company Background Information
Overview
Novadip is transforming the lives of patients using its unique "3M3" tissue regeneration technology platform. Based on the scientific discoveries of Prof. Dr. Denis Dufrane, Novadip is a spin-off company from Université Catholique de Louvain (UCLouvain) and St. Luc University Hospital. The creation of Novadip was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II. Using our unique 3M3 tissue regeneration platform, which utilizes adipose-derived stem cells within a 3-dimensional extracellular matrix, to drive multiple product classes, Novadip's mission is to provide innovative solutions for patients with limited or no effective treatment options.
Last Transaction
9/21/2026
Financing History
Management Team
Title
Name
Email & Social
Company Investors
- Invest BW
- Sambrinvest
- Wallonie Entreprendre
- Noshaq
- New Science Ventures
- Fund+
- VIVES Inter-University Fund
- SRIW
- Vives Louvain Technology Fund
- CR-CP Life Science Fund
- InvestSud
- Private Investors (Olivier Rest)
- Private Investors (Pierre Drion)
Browse more funded tech companies:
NovaDigm Therapeutics | Novaerus
Share this article
About Our VC Funding Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs








